Nadja West, a director at $THC, sold 2,178 shares of the company on 12-15-2025 for an estimated $430,089. We received data on the trade from a recent SEC filing. This was a sale of approximately 7.1% of their shares of this class of stock. Following this trade, they now own 28,480 shares of this class of $THC stock.
$THC Insider Trading Activity
$THC insiders have traded $THC stock on the open market 16 times in the past 6 months. Of those trades, 0 have been purchases and 16 have been sales.
Here’s a breakdown of recent trading of $THC stock by insiders over the last 6 months:
- SAUMYA SUTARIA (CEO) has made 0 purchases and 2 sales selling 78,762 shares for an estimated $15,026,139.
- TAMMY ROMO has made 0 purchases and 6 sales selling 27,500 shares for an estimated $5,563,324.
- R. SCOTT RAMSEY (Principal Accounting Officer) has made 0 purchases and 3 sales selling 13,322 shares for an estimated $2,732,438.
- LISA Y FOO (EVP, Chief Operating Officer) sold 8,000 shares for an estimated $1,436,240
- CHRISTOPHER S. LYNCH has made 0 purchases and 2 sales selling 3,960 shares for an estimated $698,560.
- RICHARD W FISHER sold 2,500 shares for an estimated $521,075
- NADJA WEST sold 2,178 shares for an estimated $430,089
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$THC Hedge Fund Activity
We have seen 332 institutional investors add shares of $THC stock to their portfolio, and 370 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- EMINENCE CAPITAL, LP added 1,109,450 shares (+inf%) to their portfolio in Q3 2025, for an estimated $225,262,728
- BOSTON PARTNERS added 889,283 shares (+39.4%) to their portfolio in Q3 2025, for an estimated $180,560,020
- CITADEL ADVISORS LLC removed 772,360 shares (-42.2%) from their portfolio in Q3 2025, for an estimated $156,819,974
- AQR CAPITAL MANAGEMENT LLC added 720,160 shares (+62.3%) to their portfolio in Q3 2025, for an estimated $146,221,286
- INVESCO LTD. removed 681,050 shares (-24.3%) from their portfolio in Q3 2025, for an estimated $138,280,392
- GLENVIEW CAPITAL MANAGEMENT, LLC removed 606,326 shares (-20.7%) from their portfolio in Q3 2025, for an estimated $123,108,431
- HOLOCENE ADVISORS, LP removed 584,404 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $118,657,388
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$THC Revenue
$THC had revenues of $5.3B in Q3 2025. This is an increase of 3.18% from the same period in the prior year.
You can track THC financials on Quiver Quantitative's THC stock page.
$THC Congressional Stock Trading
Members of Congress have traded $THC stock 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $THC stock by members of Congress over the last 6 months:
- REPRESENTATIVE JONATHAN L. JACKSON purchased up to $15,000 on 09/03.
- REPRESENTATIVE LISA C. MCCLAIN sold up to $15,000 on 08/04.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$THC Analyst Ratings
Wall Street analysts have issued reports on $THC in the last several months. We have seen 13 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Barclays issued a "Overweight" rating on 11/21/2025
- Wells Fargo issued a "Overweight" rating on 11/13/2025
- JP Morgan issued a "Overweight" rating on 11/13/2025
- RBC Capital issued a "Outperform" rating on 10/30/2025
- Guggenheim issued a "Buy" rating on 10/29/2025
- Cantor Fitzgerald issued a "Overweight" rating on 10/29/2025
- UBS issued a "Buy" rating on 10/29/2025
To track analyst ratings and price targets for $THC, check out Quiver Quantitative's $THC forecast page.
$THC Price Targets
Multiple analysts have issued price targets for $THC recently. We have seen 14 analysts offer price targets for $THC in the last 6 months, with a median target of $235.0.
Here are some recent targets:
- Jason Cassorla from Guggenheim set a target price of $257.0 on 12/02/2025
- Andrew Mok from Barclays set a target price of $240.0 on 11/21/2025
- Benjamin Rossi from JP Morgan set a target price of $230.0 on 11/13/2025
- Stephen Baxter from Wells Fargo set a target price of $252.0 on 11/13/2025
- David Macdonald from Truist Securities set a target price of $240.0 on 11/03/2025
- Ben Hendrix from RBC Capital set a target price of $252.0 on 10/30/2025
- A.J. Rice from UBS set a target price of $260.0 on 10/29/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
